Alimentary Pharmacology & Therapeutics

FREE: Editor's IBD Collection

Key papers within IBD, January 2013

Click below for free access to the latest IBD articles.

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient

Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease

Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

Review article: the natural history of postoperative Crohn's disease recurrence

Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study

C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease

Review article: vitamin D and inflammatory bowel disease – established concepts and future directions

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis

Review article: infliximab for Crohn's disease treatment - shifting therapeutic strategies after 10 years of clinical experience

Review article: microscopic colitis - lymphocytic, collagenous and 'mast cell' colitis

Review article: medical, surgical and radiological management of perianal Crohn's fistulas

Review article: the role of non-biological drugs in refractory inflammatory bowel disease

Review article: the optimal medical management of acute severe ulcerative colitis

Review article: remission rates achievable by current therapies for inflammatory bowel disease

Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy

Systematic review: Clostridium difficile and inflammatory bowel disease